ClinicalTrials.gg
Active, not recruitingNCT00626964SphCorUpdated Jun 11, 2025

Prevention of Coronary Heart Disease in Morbidly Obese Patients

An observational study in Morbid Obesity, Hypertension and Type 2 DM, sponsored by The Hospital of Vestfold. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-06-11.

Sponsored by The Hospital of Vestfold · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Obesity, Morbid with a site in Norway — 22 open to participants now, 26 under way, none of them phase 3. Obesity, Morbid · Norway.

Enrollment
3rd of 30
200 · median 12
Started
2008
with 2 others
Observational
30 of 51
21 open now
Primary completion
2026-12
later than 18 of 25 live
Registered
4th of 51
by date
Lead sponsor
3 of 51
The Hospital of Vestfold

Among the 51 studies in Obesity, Morbid with a site in Norway, this one is the 3rd largest by enrollment of the 30 observational ones that give a count, is one of 3 that started in 2008, is one of 30 observational ones, reaches primary completion later than 18 of the 25 other live ones, and was the 4th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

22 of the 51 studies in Obesity, Morbid with a site in Norway are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Obesity, Morbid with a site in Norway, or all of them as a file.
02

Study summary

The changes in risks of developing coronary heart disease in patients with morbid obesity after different weight loss interventions have not been extensively studied. The primary objective of this study is to investigate whether an intensive lifestyle intervention program in a tertiary care clinic (Spesialsykehuset for Rehabilitering) is comparable with a 7-week low-energy-diet followed by bariatric surgery in decreasing the risk of cardiovascular disease in these patients.

Read the detailed description

Patients matching the eligibility criteria were divided into two groups (not randomized). One group underwent a 7 weeks Low-Energy-Diet before bariatric surgery, the other group participated in an intensive lifestyle intervention program for 3 months.

Data on arterial stiffness, body weight, body composition, blood pressure, blood samples, vital parameters are registered in the both groups at baseline, 7 weeks and after 1 year.

03

Conditions studied

  • Morbid Obesity
  • Hypertension
  • Type 2 DM
  • Obstructive Sleep Apnea
  • Osteoarthrosis

Keywords

  • Arterial stiffness
  • PulseWave velocity
  • Body composition
  • Bioimpedance
  • Morbid Obesity
  • APO A
  • APO B
  • Framingham risk score
  • Prevention of Coronary Heart Disease
  • Lifestyle Intervention
  • Bariatric Surgery
  • Low Energy Diet
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Morbidly Obese patients with BMI > 40, or BMI > 35 with comorbidity such as Hypertension, Obstructive Sleep Apnea, Weight Related Osteoarthrosis, Type 2 DM.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Morbidly Obese patients with > 40, or BMI > 35 with comorbidity such as Hypertension, Obstructive Sleep Apnea, Weight Related Osteoarthrosis, Type 2 DM.

Exclusion criteria

Exclusion Criteria:

  • Participation in other weight loss program the last 12 months. Serious psychiatric conditions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Lifestyle or bariatric surgery

    Morbid Obesity with BMI \>= 40 kg/m2 or BMI \>= 35 with Comorbidity

    Procedure: Bariatric Surgery · Behavioral: Conservative Treatment:

Interventions

  • ProcedureBariatric Surgery

    Bariatric Surgery Treatment: Duodenal Switch, Gastric Sleeve or Gastric bypass.

  • BehavioralConservative Treatment:

    Intensive Lifestyle Intervention Program

    Also known as: Conservative

06

What researchers measure

Primary outcomes

  1. Arterial stiffness

    Pulse wave velocity and augmentation index

    Time frame: 7 weeks and 1 year

  2. Cardiovascular risk factors

    Several biomarkers will be examined

    Time frame: 7 weeks and 1 year

07

Study locations

1 site
08

References and documents

Publications

  • Nordstrand N, Gjevestad E, Dinh KN, Hofso D, Roislien J, Saltvedt E, Os I, Hjelmesaeth J. The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC Cardiovasc Disord. 2011 Feb 1;11:7. doi: 10.1186/1471-2261-11-7. PubMed 21284837 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2008, a primary completion of Dec 2026 and a completion of Dec 2026. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2008
First posted
Feb 29, 2008
Start
Feb 2008
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jun 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00626964
Lead sponsor
The Hospital of Vestfold
Responsible party
Jøran Hjelmesæth (Professor, The Hospital of Vestfold) — Principal investigator
First posted
Feb 29, 2008
Start date
Feb 2008
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 11, 2025

Study contacts

Jøran Hjelmesæth
principal investigator · Morbid Obesity Center, Vestfold Hospital Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion